Vaccinia Immunotherapy
Scientists at University of Texas, Cancer Center detail research in vaccinia immunotherapy
Published in Cancer Law Weekly, February 13th, 2010
Researchers detail in '5T4-modified vaccinia Ankara: progress in tumor-associated antigen-based immunotherapy,' new data in vaccinia. According to recent research from the United States, "IMPORTANCE OF THE FIELD: The expression and biology of the tumor-associated antigen (TAA) 5T4 suggest it is an effective target for cancer immunotherapy. AREAS COVERED IN THIS REVIEW: Development of a vaccine comprising highly attenuated modified vaccinia Ankara virus encoding 5T4 (MVA-5T4, a.k.a. TroVax)."
"WHAT THE READER WILL GAIN: Preclinical studies demonstrated that MVA-5T4 is safe and effective in prophylactic and active treatment of syngeneic murine tumor models. Over 700 doses...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2010-02-13)
More Articles from Cancer Law Weekly
- American Academy of Dermatology
American Academy of Dermatology Lauds U.S. Federal Trade Commission for Protecting the Public From False Health and Safety Claims About Indoor Tanning - Asbestos Disease Awareness Organization ADAO
Asbestos Disease Awareness Organization ADAO Announces New Staff and Program for 2010 - Biomoda, Inc.
Biomoda Supports Nebraska Legislation to Screen Veterans for Lung Cancer - Chase
Five California Charities Win Grants from Chase Through Facebook Program - Life Sciences
New findings from University of Surrey in the area of life sciences published - Pancreatic Cancer Action Network
President Obama's State of the Union Address: a Statement From the Pancreatic Cancer Action Network - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
